60
Participants
Start Date
May 23, 2019
Primary Completion Date
August 7, 2019
Study Completion Date
August 21, 2019
VVZ-149 Injections
IV infusion of 1000 mg of VVZ-149
Placebo
IV infusion of 0 mg of VVZ-149
JBR Clinical Research, Salt Lake City
Anaheim Clinical Trials, Anaheim
Vivozon, Inc.
INDUSTRY